Science 37 was recognized for the Participant Engagement Award for its “Pharm-to-Trial” partnership with RxE2. This decentralized vaccine trial model brings research to agricultural U.S. communities ...
MORRISVILLE, N.C., Jan. 14, 2025 (GLOBE NEWSWIRE) -- Science 37, a leader in enhancing patient access to clinical trials, announces the appointment of Tyler Van Horn as Chief Executive Officer.
RESEARCH TRIANGLE PARK, N.C., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (Nasdaq: SNCE) (the “Company” or “Science 37”), the clinical research industry’s leading Metasite TM, today ...
Science 37, Inc. will relocate its corporate headquarters from Culver City, CA to North Carolina’s Research Triangle region and create 250 jobs over five years. The clinical research company will ...
RESEARCH TRIANGLE PARK, N.C., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), the clinical research industry-leading Metasite™, today announced that it has been honored with the ...
Science 37 has been tapped to use its virtual clinical trial tech for phase 3 trials of Synlogic’s treatment for the rare genetic metabolic disorder phenylketonuria (PKU). Under the deal, Science 37’s ...
RESEARCH TRIANGLE PARK, N.C., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Science 37 Holdings, Inc. (SNCE), (“Science 37”) the Agile Clinical Trial Operating System™, today reported its financial results for ...
In a significantly oversubscribed offering, Science 37 attracted capital to support its rapid growth, expand its technology platform and accelerate global expansion. LOS ANGELES, Aug. 20, 2020 ...
LOS ANGELES & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Science 37 and Foundation Medicine today announced a collaboration to enable decentralized clinical research in oncology that will optimize recruitment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback